Product Code: ETC11388586 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Korea Anticoagulant Drugs Market Overview |
3.1 South Korea Country Macro Economic Indicators |
3.2 South Korea Anticoagulant Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 South Korea Anticoagulant Drugs Market - Industry Life Cycle |
3.4 South Korea Anticoagulant Drugs Market - Porter's Five Forces |
3.5 South Korea Anticoagulant Drugs Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 South Korea Anticoagulant Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 South Korea Anticoagulant Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 South Korea Anticoagulant Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in South Korea |
4.2.2 Growing elderly population in the country |
4.2.3 Technological advancements leading to the development of new anticoagulant drugs |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval |
4.3.2 High cost associated with anticoagulant drugs |
4.3.3 Limited awareness among the population about anticoagulant therapy |
5 South Korea Anticoagulant Drugs Market Trends |
6 South Korea Anticoagulant Drugs Market, By Types |
6.1 South Korea Anticoagulant Drugs Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 South Korea Anticoagulant Drugs Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 South Korea Anticoagulant Drugs Market Revenues & Volume, By Heparin, 2021 - 2031F |
6.1.4 South Korea Anticoagulant Drugs Market Revenues & Volume, By Warfarin, 2021 - 2031F |
6.2 South Korea Anticoagulant Drugs Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 South Korea Anticoagulant Drugs Market Revenues & Volume, By Oral, 2021 - 2031F |
6.2.3 South Korea Anticoagulant Drugs Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3 South Korea Anticoagulant Drugs Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 South Korea Anticoagulant Drugs Market Revenues & Volume, By Hospital, 2021 - 2031F |
6.3.3 South Korea Anticoagulant Drugs Market Revenues & Volume, By Retail, 2021 - 2031F |
7 South Korea Anticoagulant Drugs Market Import-Export Trade Statistics |
7.1 South Korea Anticoagulant Drugs Market Export to Major Countries |
7.2 South Korea Anticoagulant Drugs Market Imports from Major Countries |
8 South Korea Anticoagulant Drugs Market Key Performance Indicators |
8.1 Number of newly diagnosed cases of thrombosis |
8.2 Adoption rate of novel oral anticoagulants (NOACs) in clinical practice |
8.3 Rate of adherence to anticoagulant therapy among patients |
9 South Korea Anticoagulant Drugs Market - Opportunity Assessment |
9.1 South Korea Anticoagulant Drugs Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 South Korea Anticoagulant Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 South Korea Anticoagulant Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 South Korea Anticoagulant Drugs Market - Competitive Landscape |
10.1 South Korea Anticoagulant Drugs Market Revenue Share, By Companies, 2024 |
10.2 South Korea Anticoagulant Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |